New medicines launched with orphan drug designation

STO-REC-STATMFSFNNT2 National
14

Germany · 2025

New medicines launched with orphan drug designation in Germany totalled 14 in 2025 (VFA).

Original source
Publisher
VFA
Authority tier
T2 National
Locator
Medikamente gegen seltene Erkrankungen
Retrieved
17 Sep 2026
Status
Verified

What the source says

14 der Medikamente erhielten auf Antrag ihrer Hersteller von der EU den Orphan Drug-Status zuerkannt; er attestiert ihnen, zumindest für einen Teil der Erkrankten den bisherigen Behandlungsmöglichkeiten überlegen zu sein.

Verbatim extraction verified: The figure 14 is directly attested in the quoted passage (Medikamente gegen seltene Erkrankungen).

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Cite this figure

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA
VFA. (2025). Neue Medikamente in Deutschland: Innovationsbilanz 2025. Retrieved September 17, 2026, from https://www.vfa.de/de/forschung-entwicklung/meilensteine-und-neueinfuehrungen/innovationsbilanz-2025. Via StatOrigin, https://statorigin.org/stat/stat_MFSFNNEE1TKBS57HHBHWMMY3HT
MLA
VFA. "Neue Medikamente in Deutschland: Innovationsbilanz 2025." 2025, https://www.vfa.de/de/forschung-entwicklung/meilensteine-und-neueinfuehrungen/innovationsbilanz-2025. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_MFSFNNEE1TKBS57HHBHWMMY3HT.
Chicago
VFA. "Neue Medikamente in Deutschland: Innovationsbilanz 2025." 2025. https://www.vfa.de/de/forschung-entwicklung/meilensteine-und-neueinfuehrungen/innovationsbilanz-2025. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_MFSFNNEE1TKBS57HHBHWMMY3HT.
BibTeX
@misc{vfa2025medicinesmmy3ht, author = {{VFA}}, title = {Neue Medikamente in Deutschland: Innovationsbilanz 2025}, year = {2025}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_MFSFNNEE1TKBS57HHBHWMMY3HT}, note = {Original source: https://www.vfa.de/de/forschung-entwicklung/meilensteine-und-neueinfuehrungen/innovationsbilanz-2025. Accessed September 17, 2026.} }

Provenance and verification

Everything needed to check this number yourself, without taking our word for it.

Chain of Custody · Verification Audit
Record: STO-REC-STATMFSFNN T2 National

Primary Source

Publisher
VFA · homepage ↗
Authority tier
Tier 2 · National Official
Report
Neue Medikamente in Deutschland: Innovationsbilanz 2025
Type
Press release
Published
Locator
Medikamente gegen seltene Erkrankungen
Retrieved
17 September 2026
Link status
Reachable (HTTP 200)
Report licence
See source

Verification & Integrity

Audit status
Verified
Review protocol
Editorial review
Checked on
17 September 2026
Last revision
17 September 2026
Archival URI
/stat/stat_MFSFNNEE1TKBS57HHBHWMMY3HT